AssetMark Inc
FBT icon

AssetMark Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

AssetMark Inc’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Sell
24,440
-30,777
-56% -$6.63M 0.01% 686
2026
Q1 		$11.1M Buy
55,217
+8,657
+19% +$1.79M 0.02% 474
2025
Q4 		$9.62M Buy
46,560
+6,017
+15% +$1.2M 0.02% 506
2025
Q3 		$7.27M Buy
40,543
+2,452
+6% +$418K 0.02% 542
2025
Q2 		$6.15M Buy
38,091
+8,670
+29% +$1.38M 0.01% 532
2025
Q1 		$5M Buy
29,421
+1,281
+5% +$222K 0.01% 511
2024
Q4 		$4.68M Sell
28,140
-312
-1% -$53.3K 0.01% 522
2024
Q3 		$4.89M Buy
28,452
+19,978
+236% +$3.31M 0.01% 454
2024
Q2 		$1.3M Buy
8,474
+967
+13% +$145K ﹤0.01% 710
2024
Q1 		$1.15M Buy
7,507
+1,513
+25% +$231K ﹤0.01% 692
2023
Q4 		$947K Buy
5,994
+3,733
+165% +$536K ﹤0.01% 691
2023
Q3 		$331K Buy
+2,261
New +$345K ﹤0.01% 805
2022
Q1 		– Sell
-514
Closed -$83K – 1613
2021
Q4 		$83K Buy
+514
New +$83.1K ﹤0.01% 821
2020
Q4 		– Sell
-4,210
Closed -$662K – 1414
2020
Q3 		$662K Buy
4,210
+2,217
+111% +$362K ﹤0.01% 376
2020
Q2 		$334K Buy
1,993
+468
+31% +$73.5K ﹤0.01% 439
2020
Q1 		$200K Buy
1,525
+705
+86% +$100K ﹤0.01% 492
2019
Q4 		$122K Sell
820
-45
-5% -$6.18K ﹤0.01% 602
2019
Q3 		$107K Buy
865
+511
+144% +$68K ﹤0.01% 600
2019
Q2 		$50K Buy
354
+255
+258% +$35.2K ﹤0.01% 696
2019
Q1 		$15K Buy
+99
New +$14.2K ﹤0.01% 930

Other funds holding FBT

NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

AssetMark Inc's FBT Position: Q2 2026 in Review

AssetMark Inc reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 56% in Q2 2026, selling an estimated $6.63M and leaving 24,440 shares worth $6.06M. The position accounts for 0.01% of the portfolio, ranked #686.

AssetMark Inc first reported a position in FBT in Q1 2019 and has held it in 20 quarters since. The position peaked at $11.1M in Q1 2026. 143 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • AssetMark Inc held 24,440 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.06M as of Q2 2026.
  • AssetMark Inc sold 30,777 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $6.63M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of AssetMark Inc's portfolio in Q2 2026, its #686 holding.
  • AssetMark Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 20 quarters since.
  • AssetMark Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.1M in Q1 2026.
  • 143 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.